ArticleJournal of inflammation research2024

FPR1, as a Potential Biomarker of Diagnosis and Infliximab Therapy Responses for Crohn's Disease, is Related to Disease Activity, Inflammation and Macrophage Polarization.

Chenglin Ye et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.